SEC fines for­mer Mer­ck ex­ec over in­sid­er trad­ing al­le­ga­tions

The Se­cu­ri­ties and Ex­change Com­mis­sion said a for­mer Mer­ck ex­ec­u­tive agreed to pay $82,000 af­ter al­leg­ing he pur­chased shares of a com­pa­ny right be­fore it was ac­quired by the drug­mak­er.

Nir­dosh Jago­ta, a for­mer VP of glob­al reg­u­la­to­ry af­fairs at Mer­ck, bought 500 shares of Pan­dion Ther­a­peu­tics’ stock on Feb. 9, 2021, and 500 ad­di­tion­al shares on Feb. 17, 2021, ac­cord­ing to an SEC or­der an­nounced on Mon­day. Mem­bers of the ex­ec­u­tive’s team had been in­volved in the due dili­gence process lead­ing up to the deal since Jan­u­ary of that year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER